BioSig Technologies Reports Executive Changes and Compensation Adjustments
Ticker: STEX · Form: 8-K · Filed: Feb 21, 2024 · CIK: 1530766
| Field | Detail |
|---|---|
| Company | Biosig Technologies, Inc. (STEX) |
| Form Type | 8-K |
| Filed Date | Feb 21, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-changes, compensation, corporate-governance
TL;DR
**BioSig Technologies just announced executive and compensation changes, signaling a potential shake-up!**
AI Summary
BioSig Technologies, Inc. filed an 8-K on February 21, 2024, reporting an event on February 15, 2024, concerning the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. The filing indicates changes in the company's leadership and executive compensation structure. This suggests a potential restructuring or strategic shift within the company.
Why It Matters
Changes in executive leadership and compensation can signal a shift in company strategy, performance, or governance, potentially impacting future operational direction and investor confidence.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can introduce uncertainty regarding future company direction and stability.
Key Players & Entities
- BioSig Technologies, Inc. (company) — Registrant
- February 15, 2024 (date) — Date of earliest event reported
- February 21, 2024 (date) — Filing date
- Delaware (company) — State of incorporation
- 001-38659 (dollar_amount) — Commission File Number
FAQ
What was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on February 15, 2024.
What is the primary subject matter of this 8-K filing?
The primary subject matter of this 8-K filing is the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
When was this 8-K form filed with the SEC?
This 8-K form was filed with the SEC on February 21, 2024.
What is the full name of the registrant company?
The full name of the registrant company is BioSig Technologies, Inc.
In which state is BioSig Technologies, Inc. incorporated?
BioSig Technologies, Inc. is incorporated in Delaware.
Filing Stats: 529 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2024-02-21 16:05:36
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share BSGM The NASDAQ Capital M
Filing Documents
- form8-k.htm (8-K) — 36KB
- 0001493152-24-007392.txt ( ) — 204KB
- bsgm-20240215.xsd (EX-101.SCH) — 3KB
- bsgm-20240215_lab.xml (EX-101.LAB) — 33KB
- bsgm-20240215_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIOSIG TECHNOLOGIES, INC. Date: February 21, 2024 By: /s/ Kenneth L. Londoner Name: Kenneth L. Londoner Title: Executive Chairman